-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Cardiovascular system
Pentoxifylline Sustained-Release Tablets
[Generic Name] Pentoxifylline Sustained-Release Tablets
[Approval Number] National Drug Approval No. H20233310
【Specification】0.4 g × 10 tablets/box
【Packaging】Aluminum-plastic blister pack
【Dosage Form】Tablets
Felodipine Extended-Release Tablets
[Generic Name] Felodipine Sustained-Release Tablets
[Approval Number] National Drug Approval No. H20223964
【Specification】5 mg × 24 tablets/box; 5 mg × 48 tablets/box
【Packaging】Aluminum-plastic blister pack
【Dosage Form】Tablets
Pentoxifylline Injection
[Generic Name] Pentoxifylline Injection
[Approval Number] National Drug Approval No. H20223704
【Specification】5 ml: 0.1 g
【Packaging】Polypropylene ampoules
【Dosage Form】Injection
Valsartan and Amlodipine Tablets (I)
[Generic Name] Valsartan Amlodipine Tablets (I)
[Approval Number] National Drug Approval No. H20223692
【Specification】Each tablet contains 80 mg of valsartan and 5 mg of amlodipine.
【Packaging】Aluminum-plastic blister pack
【Dosage Form】Tablets
Mountain Lotus Oral Liquid
[Generic Name] Shanhe Oral Liquid
[Approval Number] National Drug Approval No. B20020373
【Specification】10 ml × 10 vials/box × 80 boxes/carton
【Packaging】Glass bottle
Rosuvastatin Calcium Tablets
[Generic Name] Rosuvastatin Calcium Tablets
[Approval Number] National Drug Approval No. H20203427
【Specification】10 mg × 28 tablets; 10 mg × 14 tablets
【Packaging】Dual-aluminum packaging
【Medical Insurance】National Medical Insurance Category B
Adenosine Cyclophosphate Injection
[Generic Name] Adenosine Cyclophosphate Injection
[Approval Number] National Drug Approval No. H20051363
【Specification】2 ml: 20 mg
【Packaging】Glass ampoules
【Medical Insurance】National Medical Insurance Category B
Citicoline Sodium and Glucose Injection
[Generic Name] Cytidine Diphosphate Choline Sodium Glucose Injection
[Approval Number] National Drug Approval No. H20067942
【Specification】100 ml: Sodium Cytidine Diphosphate Choline 0.25 g and Glucose 5.0 g
【Packaging】Glass bottle
【Medical Insurance】National Medical Insurance Category B
Pentoxifylline Sodium Chloride Injection
[Generic Name] Pentoxifylline Sodium Chloride Injection
[Approval Number] National Drug Approval No. H20068082
【Specification】100 ml: 0.1 g of pentoxifylline and 0.9 g of sodium chloride
【Packaging】Non-PVC soft bag/PP bottle
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
